Skip To Main Content
Irina Popova on Muck Rack

Irina Popova

Milan
As seen in: Medium, The Guardian, MDPI, BioRxiv, Cell Press, National Bureau of Economic Research, Journal of Organizational Change Management, eLife, Nuclear Newswire, European Journal of Vascular and Endovascular Surgery and
A Russian studying and working in Milan

Get in touch with Irina

Contact Irina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Irina Popova’s Biography

Read Full Bio →

Russian, Master student in Economics&Management in Arts, Culture, Media and Entertainment at Bocconi University, Milan. Working in the press office of the arts association Maga Global Arts Around the World.

Articles

Articles Tagged with: spallation neutron source -- ANS

|
By Irina Popova
| Nuclear Newswire Verified
A scientist at ORNL’s Spallation Neutron Source aligns a neutron beam collimator to facilitate neutron scattering measurements on TRISO fuel. (Photo: Will Cureton/ORNL) Oak Ridge National Laboratory is reporting a development in TRISO fuel research that could help evaluate high-temperature gas reactor fuels.
Open in Who Shared Issue with article?

Articles Tagged with: radiation protection -- ANS

|
By Irina Popova, Henry Hickling, Brian Dassatti, Kamila Blain
| Nuclear Newswire Verified
Three authorities on health physics have written a response to President Trump’s Executive Order 14300, “Ordering the Reform of the Nuclear Regulatory Commission.” Published June 27 on Substack, “Radiation Protection Policy in a Nuclear Era: Recommendations from Health Physicists in Response to EO 14300” was written by Emily A. Caffrey, assistant professor and director of the Health Physics Program at the University of Alabama–Birmingham; Amir A.
Open in Who Shared View Duplicates (2) Issue with article?

Nucleosome context regulates chromatin reader preference

|
By Matthew R Marunde, Irina Popova, Nathan Hall, Anup S. Vaidya
| BioRxiv
EpiCypher is a commercial developer and supplier of reagents (e.g., PTM-defined semi-synthetic nucleosomes) and platforms (e.g., Captify and CUTANA) used in this study. All EpiCypher authors own shares in the company with J.R.B., M.W.C. and M.-C.K. also directors of same. EpiCypher holds patents related to technologies used in this study (#WO2019173565A1, #WO2020132388A1 and #WO2023159045A1) with M.R.M., E.N.W., B.J.V., Z.W.S., M.W.C., M.-C.K., and J.M.B. as listed inventors.
Open in Who Shared Issue with article?
See all 19 licensed articles (21 Total)